2022
DOI: 10.3390/biom12091166
|View full text |Cite
|
Sign up to set email alerts
|

Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance

Abstract: The heat shock protein 90 (Hsp90) is a molecular chaperone and a key regulator of proteostasis under both physiological and stress conditions. In mammals, there are two cytosolic Hsp90 isoforms: Hsp90α and Hsp90β. These two isoforms are 85% identical and encoded by two different genes. Hsp90β is constitutively expressed and essential for early mouse development, while Hsp90α is stress-inducible and not necessary for survivability. These two isoforms are known to have largely overlapping functions and to intera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(13 citation statements)
references
References 189 publications
0
13
0
Order By: Relevance
“…We synthesized [ [20]. Although we did not con rm this ligand's a nity for other HSP90 isoforms in this study, other studies suggested that this ligand does not have any signi cant a nity for other HSP90 isoforms [17].…”
Section: Radiosynthesismentioning
confidence: 55%
“…We synthesized [ [20]. Although we did not con rm this ligand's a nity for other HSP90 isoforms in this study, other studies suggested that this ligand does not have any signi cant a nity for other HSP90 isoforms [17].…”
Section: Radiosynthesismentioning
confidence: 55%
“…The lack of specificity in these inhibitors, largely due to the sequence identity among the four HSP90 isoforms, particularly the 85% similarity between HSP90α and HSP90β, remains a significant limitation. 9,279 Therefore, it is important to continue research on isoform-selective inhibitors, with the aim of mitigating generalized HSP90 inhibition. For instance, Mishra et al 280,281 analyzed differences between Hsp90α and Hsp90β in the ATP binding site, then used fluorescence assays to create highly selective inhibitors for Hsp90α and Hsp90β without raising Hsp90 levels, a significant advance in isoform-selective inhibitors.…”
Section: Conclusion and Prospectsmentioning
confidence: 99%
“…As of now, only one HSP90 inhibitor, pimitespib, has gained approval in Japan for GIST treatment. The lack of specificity in these inhibitors, largely due to the sequence identity among the four HSP90 isoforms, particularly the 85% similarity between HSP90α and HSP90β, remains a significant limitation 9,279 . Therefore, it is important to continue research on isoform‐selective inhibitors, with the aim of mitigating generalized HSP90 inhibition.…”
Section: Conclusion and Prospectsmentioning
confidence: 99%
“…In mammalian cells, HSP90 exists in two paralogs, HSP90α and HSP90β 39 , both of which have been reported to play roles in epichaperome formation in cancer cells 13 . To assess the isoform composition of HSP90 within epichaperomes, we exploited the subtle difference between one pair of isobaric peptides, namely 88Thr-Lys100 in HSP90α and 83Thr-Lys95 in HSP90β, where a single amino acid distinguishes them (Ile in HSP90α and Leu in HSP90β) (Supplementary Fig.…”
Section: Pluripotent Stem Cells and Cancer Cells Share Epichaperomesmentioning
confidence: 99%